Effects of Chest Wall Elastance on Pulmonary Mechanics of Acute Respiratory Failure (ARF)

Sponsor
Southeast University, China (Other)
Overall Status
Completed
CT.gov ID
NCT02196870
Collaborator
(none)
12
1
11
1.1

Study Details

Study Description

Brief Summary

Patients with chest wall elastance increasing could worsen lung function. Increasing of chest wall elastance plays a great role in lung mechanics, and could influence mechanical ventilation settings. Therefore, It could help the physicians to find appropriate indicators and optimize the treatments of ARF patients to explore the mechanisms of lung mechanics changse in the patients with high chest wall elastance.

Detailed Description

Mechanical ventilation(MV) is an important treatment for acute respiratory failure(ARF) patients, could improve hypoxemia, maintain lung volume and promote alveolar opening. However, because of barotrauma, volutrauma and biotrauma, MV could cause or aggravate acute lung injury not only in acute respiratory distress syndrome(ARDS) patients, but in patients with normal lung function1,2.

Patients with chest wall elastance increasing could worsen lung function. Increasing of chest wall elastance plays a great role in lung mechanics, and could influence mechanical ventilation settings. Therefore, It could help the physicians to find appropriate indicators and optimize the treatments of ARF patients to explore the mechanisms of lung mechanics changse in the patients with high chest wall elastance.

The present study is set out to examine the effects of high chest wall elastance on changes of lung mechanics and the correlation of airway pressure(Paw) stress index and transpulmonary pressure(PL) stress index.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
12 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Physiological Effects of Chest Wall Elastance on Pulmonary Mechanics of Acute Respiratory Failure Patientstranspulmonary Pressure
Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Outcome Measures

Primary Outcome Measures

  1. Changes of oxygenation and lung mechanics [up to 24 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ARF

  • mechanical ventilation

  • cardiovascular stable

Exclusion Criteria:
  • age < 18y or > 85y

  • pregnancy

  • COPD or chronic pulmonary disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongda Hospital Nanjing Jiangsu China 210009

Sponsors and Collaborators

  • Southeast University, China

Investigators

  • Principal Investigator: Jianfeng Xie, Dr., Zhongda hospital, Southeast University, Jiangsu, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jianfeng Xie, Department of Critical Care Medicine, Zhong-Da Hospital, Southeast University, China
ClinicalTrials.gov Identifier:
NCT02196870
Other Study ID Numbers:
  • Chest wall Elastance in ARF
First Posted:
Jul 22, 2014
Last Update Posted:
Jun 24, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Jianfeng Xie, Department of Critical Care Medicine, Zhong-Da Hospital, Southeast University, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 24, 2015